From a genome-wide screen of rnai molecules against sars-cov-2 to a validated broad-spectrum and potent prophylaxis

HIGHLIGHTS

• who: Ohad Yogev from the University of, Cambridge, United Kingdom have published the article: From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis, in the Journal: (JOURNAL) of 29/Oct/2022
• what: Next the authors focused on the sequence features of the shRNAs . In each batch of the experiments an siRNA against eGFP was used as a negative control (left panel n = 3 right panel n = 1 error bars=SEM significance was calculated using t-test); Viral load of SARS-CoV-2 (ancestral strain . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.